Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2 <sup>+</sup> breast cancer
Aaron G. Baugh(University of Southern California), Evanthia T. Roussos Torres(University of Southern California)
Cited by 0
Related Papers
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial
|Nature Cancer|2024|46
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)
|Clinical Cancer Research|2021|35
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer
|Clinical & Experimental Metastasis|2024|6
A class act: HDAC1- <i>Malat1</i> regulates MDSC apoptosis and cell cycling to decrease suppression of T cells
|bioRxiv (Cold Spring Harbor Laboratory)|2026|1